Related Experiment Video
Updated: Nov 6, 2025

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
CHA2DS2-VASc Score and Risk of New-Onset Peripheral Arterial Occlusive Disease in Patients without Atrial
Tzu-Chieh Lin1, Ho-Ming Su1,2,3, Wen-Hsien Lee1,2,3
1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University.
Insights
The CHA₂DS₂-VASc score effectively predicts new-onset peripheral artery occlusive disease (PAOD) in patients without atrial fibrillation. This score demonstrates superior predictive power compared to CHADS₂ and R₂CHADS₂ scores for identifying PAOD risk.
Area of Science:
- Cardiovascular Medicine
- Epidemiology
- Vascular Disease Research
Background:
- The CHA₂DS₂-VASc score is established for assessing stroke risk in atrial fibrillation (AF) patients, outperforming the CHADS₂ score.
- Previous research indicated a correlation between the CHA₂DS₂-VASc score and reduced ankle-brachial index.
- The current study investigates the predictive capability of the CHA₂DS₂-VASc score for new-onset peripheral artery occlusive disease (PAOD).
Purpose of the Study:
- To determine if the CHA₂DS₂-VASc score can predict new-onset PAOD.
- To compare the predictive performance of CHA₂DS₂-VASc score against CHADS₂ and R₂CHADS₂ scores for PAOD.
- To evaluate the CHA₂DS₂-VASc score's utility in a general patient population without AF.
Main Methods:
- Utilized the National Health Insurance Research Database, analyzing 723,750 patients from 2000-2001.
- Calculated CHADS₂, R₂CHADS₂, and CHA₂DS₂-VASc scores for all patients.
- Followed patients for new-onset PAOD over approximately 9.8 years, categorizing them by CHA₂DS₂-VASc score groups.
Main Results:
- 24,775 patients (3.4%) developed new-onset PAOD during the follow-up period.
- PAOD occurrence rates significantly increased with higher CHA₂DS₂-VASc scores, from 1.3% to 23.4%.
- Multivariate analysis confirmed that CHA₂DS₂-VASc scores of 2-9 were significantly associated with new-onset PAOD, and the score outperformed CHADS₂ and R₂CHADS₂.
Conclusions:
- The CHA₂DS₂-VASc score is a potent predictor of new-onset PAOD in individuals without atrial fibrillation.
- It offers superior predictive accuracy for PAOD compared to the CHADS₂ and R₂CHADS₂ scores.
- This finding supports the broader application of the CHA₂DS₂-VASc score in vascular risk assessment.
Background:
CHA2DS2-VASc score is a useful score to evaluate the risk of stroke in patients with atrial fibrillation (AF), and it has been shown to outperform CHADS2 score. Our recent cross-sectional study showed that CHA2DS2-VASc score was associated with an ankle-brachial index < 0.9. The aim of the current study was to evaluate whether CHA2DS2-VASc score is a useful predictor of new-onset peripheral artery occlusive disease (PAOD) and whether it can outperform CHADS2 and R2CHADS2 scores.
Methods:
We used the National Health Insurance Research Database to survey 723750 patients from January 1, 2000 to December 31, 2001. CHADS2, R2CHADS2, and CHA2DS2-VASc scores were calculated for every patient. Finally, 280176 (score 0), 307209 (score 1), 61093 (score 2), 35594 (score 3), 18956 (score 4), 11032 (score 5), 6006 (score 6), 2696 (score 7), 843 (score 8), and 145 (score 9) patients were studied and followed to evaluate new-onset PAOD. We further divided the study patients into six groups: group 1 (score 0), group 2 (score 1-2), group 3 (score 3-4), group 4 (score 5-6), group 5 (score 7-8), and group 6 (score 9).
Results:
Overall, 24775 (3.4%) patients experienced new-onset PAOD during 9.8 years of follow-up. The occurrence rate of PAOD increased from 1.3% (group 1) to 23.4% (group 6). Subgroup analysis by gender also showed an association between CHA2DS2-VASc score and the occurrence rate of PAOD. After multivariate analysis, groups 2-6 were significantly associated with new-onset PAOD. CHA2DS2-VASc score also outperformed CHADS2 and R2CHADS2 scores for predicting new-onset PAOD.
Conclusions:
CHA2DS2-VASc score was a more powerful predictor of new-onset PAOD than CHADS2 and R2CHADS2 scores in patients without AF.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Peripheral Artery Disease I: Introduction
Assessment of blood pressure in brachial artery(two-step method)
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

